Long‐term opioid therapy definitions and predictors: A systematic review

Purpose This review sought to (a) describe definitions of long‐term opioid therapy (LTOT) outcome measures, and (b) identify the predictors associated with the transition from short‐term opioid use to LTOT for opioid‐naïve individuals. Methods We conducted a systematic review of the peer‐reviewed li...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacoepidemiology and drug safety 2020-03, Vol.29 (3), p.252-269
Hauptverfasser: Karmali, Ruchir N., Bush, Christopher, Raman, Sudha R., Campbell, Cynthia I., Skinner, Asheley C., Roberts, Andrew W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 269
container_issue 3
container_start_page 252
container_title Pharmacoepidemiology and drug safety
container_volume 29
creator Karmali, Ruchir N.
Bush, Christopher
Raman, Sudha R.
Campbell, Cynthia I.
Skinner, Asheley C.
Roberts, Andrew W.
description Purpose This review sought to (a) describe definitions of long‐term opioid therapy (LTOT) outcome measures, and (b) identify the predictors associated with the transition from short‐term opioid use to LTOT for opioid‐naïve individuals. Methods We conducted a systematic review of the peer‐reviewed literature (January 2007 to July 2018). We included studies examining opioid use for more than 30 days. We classified operationalization of LTOT based on criteria used in the definitions. We extracted LTOT predictors from multivariate models in studies of opioid‐naïve individuals. Results The search retrieved 5,221 studies, and 34 studies were included. We extracted 41 unique variations of LTOT definitions. About 36% of definitions required a cumulative duration of opioid use of 3 months. Only 17% of definitions considered consecutive observation periods, 27% used days' supply, and no definitions considered dose. We extracted 76 unique predictors of LTOT from seven studies of opioid‐naïve patients. Common predictors included pre‐existing comorbidities (21.1%), non‐opioid prescription medication use (13.2%), substance use disorders (10.5%), and mental health disorders (10.5%). Conclusions Most LTOT definitions aligned with the chronic pain definition (pain more than 3 months), and used cumulative duration of opioid use as a criterion, although most did not account for consistent use. Definitions were varied and rarely accounted for prescription characteristics, such as days' supply. Predictors of LTOT were similar to known risk factors of opioid abuse, misuse, and overdose. As LTOT becomes a central component of quality improvement efforts, researchers should incorporate criteria to identify consistent opioid use to build the evidence for safe and appropriate use of prescription opioids.
doi_str_mv 10.1002/pds.4929
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7058495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2328771979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4389-813b061fb3ed476b98963e649e5469097b0f464d051bfe615063cb0c209c6df93</originalsourceid><addsrcrecordid>eNp1kctKxTAQhoMo3sEnkIIbN9WkuTUuBPEuBxTUdWiTqUbapiY9ytn5CD6jT2KPdwVXE5iPb2byI7RG8BbBONvubNxiKlMzaJFgpVLCuZydvjlNcy7UAlqK8Q7joafYPFqgJOdESrqIzka-vXl5eu4hNInvnHc26W8hFN0ksVC51vXOtzEpWpt0AawzvQ9xJ9lL4iT20BS9M0mABwePK2iuKuoIqx91GV0fHV7tn6Sj8-PT_b1RahjNVZoTWmJBqpKCZVKUKleCgmAKOBMKK1niiglmMSdlBYJwLKgpscmwMsJWii6j3XdvNy4bsAbaPhS17oJrijDRvnD6d6d1t_rGP2iJec4UHwSbH4Lg78cQe924aKCuixb8OOqMZrmURMnprI0_6J0fh3Y4b6AkHv6QE_YtNMHHGKD6WoZgPQ1IDwHpaUADuv5z-S_wM5EBSN-BR1fD5F-Rvji4fBO-AovVmug</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2370177514</pqid></control><display><type>article</type><title>Long‐term opioid therapy definitions and predictors: A systematic review</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Karmali, Ruchir N. ; Bush, Christopher ; Raman, Sudha R. ; Campbell, Cynthia I. ; Skinner, Asheley C. ; Roberts, Andrew W.</creator><creatorcontrib>Karmali, Ruchir N. ; Bush, Christopher ; Raman, Sudha R. ; Campbell, Cynthia I. ; Skinner, Asheley C. ; Roberts, Andrew W.</creatorcontrib><description>Purpose This review sought to (a) describe definitions of long‐term opioid therapy (LTOT) outcome measures, and (b) identify the predictors associated with the transition from short‐term opioid use to LTOT for opioid‐naïve individuals. Methods We conducted a systematic review of the peer‐reviewed literature (January 2007 to July 2018). We included studies examining opioid use for more than 30 days. We classified operationalization of LTOT based on criteria used in the definitions. We extracted LTOT predictors from multivariate models in studies of opioid‐naïve individuals. Results The search retrieved 5,221 studies, and 34 studies were included. We extracted 41 unique variations of LTOT definitions. About 36% of definitions required a cumulative duration of opioid use of 3 months. Only 17% of definitions considered consecutive observation periods, 27% used days' supply, and no definitions considered dose. We extracted 76 unique predictors of LTOT from seven studies of opioid‐naïve patients. Common predictors included pre‐existing comorbidities (21.1%), non‐opioid prescription medication use (13.2%), substance use disorders (10.5%), and mental health disorders (10.5%). Conclusions Most LTOT definitions aligned with the chronic pain definition (pain more than 3 months), and used cumulative duration of opioid use as a criterion, although most did not account for consistent use. Definitions were varied and rarely accounted for prescription characteristics, such as days' supply. Predictors of LTOT were similar to known risk factors of opioid abuse, misuse, and overdose. As LTOT becomes a central component of quality improvement efforts, researchers should incorporate criteria to identify consistent opioid use to build the evidence for safe and appropriate use of prescription opioids.</description><identifier>ISSN: 1053-8569</identifier><identifier>EISSN: 1099-1557</identifier><identifier>DOI: 10.1002/pds.4929</identifier><identifier>PMID: 31851773</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Abuse ; analgesics ; Analgesics, Opioid - therapeutic use ; Chronic pain ; Chronic Pain - drug therapy ; Humans ; Narcotics ; opioid ; Opioids ; outcome measurement errors ; Overdose ; Quality control ; Risk factors ; Systematic review</subject><ispartof>Pharmacoepidemiology and drug safety, 2020-03, Vol.29 (3), p.252-269</ispartof><rights>2019 John Wiley &amp; Sons, Ltd.</rights><rights>2020 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4389-813b061fb3ed476b98963e649e5469097b0f464d051bfe615063cb0c209c6df93</citedby><cites>FETCH-LOGICAL-c4389-813b061fb3ed476b98963e649e5469097b0f464d051bfe615063cb0c209c6df93</cites><orcidid>0000-0003-0022-0946</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpds.4929$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpds.4929$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31851773$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karmali, Ruchir N.</creatorcontrib><creatorcontrib>Bush, Christopher</creatorcontrib><creatorcontrib>Raman, Sudha R.</creatorcontrib><creatorcontrib>Campbell, Cynthia I.</creatorcontrib><creatorcontrib>Skinner, Asheley C.</creatorcontrib><creatorcontrib>Roberts, Andrew W.</creatorcontrib><title>Long‐term opioid therapy definitions and predictors: A systematic review</title><title>Pharmacoepidemiology and drug safety</title><addtitle>Pharmacoepidemiol Drug Saf</addtitle><description>Purpose This review sought to (a) describe definitions of long‐term opioid therapy (LTOT) outcome measures, and (b) identify the predictors associated with the transition from short‐term opioid use to LTOT for opioid‐naïve individuals. Methods We conducted a systematic review of the peer‐reviewed literature (January 2007 to July 2018). We included studies examining opioid use for more than 30 days. We classified operationalization of LTOT based on criteria used in the definitions. We extracted LTOT predictors from multivariate models in studies of opioid‐naïve individuals. Results The search retrieved 5,221 studies, and 34 studies were included. We extracted 41 unique variations of LTOT definitions. About 36% of definitions required a cumulative duration of opioid use of 3 months. Only 17% of definitions considered consecutive observation periods, 27% used days' supply, and no definitions considered dose. We extracted 76 unique predictors of LTOT from seven studies of opioid‐naïve patients. Common predictors included pre‐existing comorbidities (21.1%), non‐opioid prescription medication use (13.2%), substance use disorders (10.5%), and mental health disorders (10.5%). Conclusions Most LTOT definitions aligned with the chronic pain definition (pain more than 3 months), and used cumulative duration of opioid use as a criterion, although most did not account for consistent use. Definitions were varied and rarely accounted for prescription characteristics, such as days' supply. Predictors of LTOT were similar to known risk factors of opioid abuse, misuse, and overdose. As LTOT becomes a central component of quality improvement efforts, researchers should incorporate criteria to identify consistent opioid use to build the evidence for safe and appropriate use of prescription opioids.</description><subject>Abuse</subject><subject>analgesics</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Chronic pain</subject><subject>Chronic Pain - drug therapy</subject><subject>Humans</subject><subject>Narcotics</subject><subject>opioid</subject><subject>Opioids</subject><subject>outcome measurement errors</subject><subject>Overdose</subject><subject>Quality control</subject><subject>Risk factors</subject><subject>Systematic review</subject><issn>1053-8569</issn><issn>1099-1557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctKxTAQhoMo3sEnkIIbN9WkuTUuBPEuBxTUdWiTqUbapiY9ytn5CD6jT2KPdwVXE5iPb2byI7RG8BbBONvubNxiKlMzaJFgpVLCuZydvjlNcy7UAlqK8Q7joafYPFqgJOdESrqIzka-vXl5eu4hNInvnHc26W8hFN0ksVC51vXOtzEpWpt0AawzvQ9xJ9lL4iT20BS9M0mABwePK2iuKuoIqx91GV0fHV7tn6Sj8-PT_b1RahjNVZoTWmJBqpKCZVKUKleCgmAKOBMKK1niiglmMSdlBYJwLKgpscmwMsJWii6j3XdvNy4bsAbaPhS17oJrijDRvnD6d6d1t_rGP2iJec4UHwSbH4Lg78cQe924aKCuixb8OOqMZrmURMnprI0_6J0fh3Y4b6AkHv6QE_YtNMHHGKD6WoZgPQ1IDwHpaUADuv5z-S_wM5EBSN-BR1fD5F-Rvji4fBO-AovVmug</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Karmali, Ruchir N.</creator><creator>Bush, Christopher</creator><creator>Raman, Sudha R.</creator><creator>Campbell, Cynthia I.</creator><creator>Skinner, Asheley C.</creator><creator>Roberts, Andrew W.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0022-0946</orcidid></search><sort><creationdate>202003</creationdate><title>Long‐term opioid therapy definitions and predictors: A systematic review</title><author>Karmali, Ruchir N. ; Bush, Christopher ; Raman, Sudha R. ; Campbell, Cynthia I. ; Skinner, Asheley C. ; Roberts, Andrew W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4389-813b061fb3ed476b98963e649e5469097b0f464d051bfe615063cb0c209c6df93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abuse</topic><topic>analgesics</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Chronic pain</topic><topic>Chronic Pain - drug therapy</topic><topic>Humans</topic><topic>Narcotics</topic><topic>opioid</topic><topic>Opioids</topic><topic>outcome measurement errors</topic><topic>Overdose</topic><topic>Quality control</topic><topic>Risk factors</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karmali, Ruchir N.</creatorcontrib><creatorcontrib>Bush, Christopher</creatorcontrib><creatorcontrib>Raman, Sudha R.</creatorcontrib><creatorcontrib>Campbell, Cynthia I.</creatorcontrib><creatorcontrib>Skinner, Asheley C.</creatorcontrib><creatorcontrib>Roberts, Andrew W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pharmacoepidemiology and drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karmali, Ruchir N.</au><au>Bush, Christopher</au><au>Raman, Sudha R.</au><au>Campbell, Cynthia I.</au><au>Skinner, Asheley C.</au><au>Roberts, Andrew W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long‐term opioid therapy definitions and predictors: A systematic review</atitle><jtitle>Pharmacoepidemiology and drug safety</jtitle><addtitle>Pharmacoepidemiol Drug Saf</addtitle><date>2020-03</date><risdate>2020</risdate><volume>29</volume><issue>3</issue><spage>252</spage><epage>269</epage><pages>252-269</pages><issn>1053-8569</issn><eissn>1099-1557</eissn><abstract>Purpose This review sought to (a) describe definitions of long‐term opioid therapy (LTOT) outcome measures, and (b) identify the predictors associated with the transition from short‐term opioid use to LTOT for opioid‐naïve individuals. Methods We conducted a systematic review of the peer‐reviewed literature (January 2007 to July 2018). We included studies examining opioid use for more than 30 days. We classified operationalization of LTOT based on criteria used in the definitions. We extracted LTOT predictors from multivariate models in studies of opioid‐naïve individuals. Results The search retrieved 5,221 studies, and 34 studies were included. We extracted 41 unique variations of LTOT definitions. About 36% of definitions required a cumulative duration of opioid use of 3 months. Only 17% of definitions considered consecutive observation periods, 27% used days' supply, and no definitions considered dose. We extracted 76 unique predictors of LTOT from seven studies of opioid‐naïve patients. Common predictors included pre‐existing comorbidities (21.1%), non‐opioid prescription medication use (13.2%), substance use disorders (10.5%), and mental health disorders (10.5%). Conclusions Most LTOT definitions aligned with the chronic pain definition (pain more than 3 months), and used cumulative duration of opioid use as a criterion, although most did not account for consistent use. Definitions were varied and rarely accounted for prescription characteristics, such as days' supply. Predictors of LTOT were similar to known risk factors of opioid abuse, misuse, and overdose. As LTOT becomes a central component of quality improvement efforts, researchers should incorporate criteria to identify consistent opioid use to build the evidence for safe and appropriate use of prescription opioids.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31851773</pmid><doi>10.1002/pds.4929</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0003-0022-0946</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1053-8569
ispartof Pharmacoepidemiology and drug safety, 2020-03, Vol.29 (3), p.252-269
issn 1053-8569
1099-1557
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7058495
source MEDLINE; Wiley Online Library All Journals
subjects Abuse
analgesics
Analgesics, Opioid - therapeutic use
Chronic pain
Chronic Pain - drug therapy
Humans
Narcotics
opioid
Opioids
outcome measurement errors
Overdose
Quality control
Risk factors
Systematic review
title Long‐term opioid therapy definitions and predictors: A systematic review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T11%3A25%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%E2%80%90term%20opioid%20therapy%20definitions%20and%20predictors:%20A%20systematic%20review&rft.jtitle=Pharmacoepidemiology%20and%20drug%20safety&rft.au=Karmali,%20Ruchir%20N.&rft.date=2020-03&rft.volume=29&rft.issue=3&rft.spage=252&rft.epage=269&rft.pages=252-269&rft.issn=1053-8569&rft.eissn=1099-1557&rft_id=info:doi/10.1002/pds.4929&rft_dat=%3Cproquest_pubme%3E2328771979%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2370177514&rft_id=info:pmid/31851773&rfr_iscdi=true